Puerto, Reynalyn B.

HRN: 19-29-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
CEFUROXIME 750MG (VIAL)
06/01/2023
06/07/2023
IV
750mg
Q8h
Pre-auricular Mass Left
06/02/2023
MUPIROCIN 2%, 15G (TUBE)
06/02/2023
06/09/2023
TOPICAL
1g
Bid
Infected Epidermal Inclusion Cyst
Waiting Final Action 
06/02/2023
CLINDAMYCIN 300MG (CAP)
06/02/2023
06/09/2023
PO
300mg
Q6h
Infected Epidermal Inclusion Cyst
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: